Cytomegalovirus in the eye and its link to age-related macular degeneration

Ocular MCMV latency and AMD-like pathology

NIH-funded research Augusta University · NIH-11303299

This project looks at whether a common herpesvirus that can persist in eye cells contributes to the inflammation and abnormal blood vessels seen in age-related macular degeneration in older adults.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionAugusta University NIH-funded
Lab location1 site (Augusta, United States)
Project IDNIH-11303299 on NIH RePORTER

What this research studies

You should know scientists are using mouse models where cytomegalovirus infects and becomes latent in the retinal pigment epithelium and choroid to mimic features of human AMD. They combine viral latency with stressors like light damage and genetic depletion of an antioxidant enzyme in retinal cells to see if the virus reactivates and sparks inflammatory and blood-vessel changes. The team will track retinal and choroidal structure, deposits, degeneration of supporting cells, and lesions similar to choroidal neovascularization as the mice age. Results will be compared with human findings linking cytomegalovirus antibodies and viral DNA in eye tissue to clarify possible viral contributions to AMD.

Who could benefit from this research

Good fit: This work is most relevant to older adults with age-related macular degeneration or people with signs of choroidal neovascularization and evidence of prior cytomegalovirus exposure.

Not a fit: Because this is preclinical laboratory research using mouse models, patients seeking immediate therapeutic benefits are unlikely to benefit directly.

Why it matters

Potential benefit: If confirmed, this work could point to viral-driven inflammation as a target for preventing or treating some forms of AMD.

How similar studies have performed: Previous human studies have reported associations between cytomegalovirus markers and neovascular AMD and prior mouse work has produced AMD-like changes after CMV infection, but a direct causal role in people remains unproven.

Where this research is happening

Augusta, United States

Researchers

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Last reviewed 2026-06-10 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.